Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Hepatitis B

Metabolomics-guided machine learning reveals diagnostic and mechanistic biomarkers in CHB with MASLD

Chuyang Wang, Yutao Chen, [ ... ], Qubo Chen

Construction of a depression risk prediction model for hepatitis B patients based on machine learning strategy

Siyi Wang, Haoqi Liu, [ ... ], Rongjuan Guo

Modeling HBV transmission dynamics in Indonesia (2024–2030) using a SIVRM model: Evaluating optimal control strategies for elimination by 2030

Hashem S. Arkok, Tri Yunis Miko Wahyono, Dipo Aldila, Nurhayati Adnan Prihartono

Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study

Chanavee Toh, Kedsiree Sanit, [ ... ], Apichat Kaewdech

Serology change-based clinical interpretation of indeterminate serostatus post-hepatitis B virus infection in people living with HIV

Ei Kinai, Mio Ishikura, [ ... ], Kagehiro Amano

Barriers and facilitators to HIV and viral hepatitis testing in primary healthcare settings in the Kyrgyz Republic: A mixed-methods study using the COM-B Framework

Ida Sperle, Nikolay Lunchenkov, [ ... ], Sandra Dudareva

Antibody response to tetanus, diphtheria, poliomyelitis, hepatitis B, and H. influenzae b vaccines in allogeneic hematopoietic stem cell transplant adult recipients: A multicenter trial

Olivier Epaulard, Martin Carré, [ ... ], Anne Thiebault

Comparative evaluation of four fully automated immunoanalyzers for the simultaneous detection of HBeAg and Anti-HBe

Junhyup Song, Seung Jun Choi, Sinyoung Kim, Younhee Park

Epidemiological trends and projections to 2035 of hepatitis B burden in China, 1990–2021

Xinyue Qi, Yongzheng Hu, Wei Jiang

Exploring the combined impact of hepatitis B antibody status and systemic immune-inflammation index on mortality risk: A population-based study

Di Zeng, Shaofeng Wang, [ ... ], Jiong Lu

Tenofovir alafenamide is superior to tenofovir disoproxil fumarate and entecavir in cost-effectiveness of treatment of chronic hepatitis B in china with new volume-based procurement policy

Yi Lin, Xueyan Lin, [ ... ], Shiyun Lu

Hepatitis B (HBsAg) prevalence among obstetric patients in Caluquembe, Angola, 2023–2024

Anna E. Eberwein, Priscila Ribeiro Cummings, [ ... ], Kathryn H. Jacobsen

A real-world disproportionality analysis of Tenofovir Alafenamide (TAF): Data mining of the FDA adverse event reporting system (FAERS)

Chao Zhang, Jiaqi Wen, Yinghui Li

Advertisement

Create a weekly email alert for: Hepatitis B

You can change these options by clicking profile then "Alerts and Notifications"